STOCK TITAN
  1. Home
  2. News
  3. RVP

Retractable Technologies, Inc - $RVP STOCK NEWS

Welcome to our dedicated page for Retractable Technologies news (Ticker: $RVP), a resource for investors and traders seeking the latest updates and insights on Retractable Technologies stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Retractable Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Retractable Technologies's position in the market.

News
Retractable Technologies, Inc. Reports Results for 2023
Rhea-AI Summary
Retractable Technologies, Inc. (RVP) reports a 54.0% decrease in revenues for 2023 due to lower COVID-19 vaccination sales. Domestic revenues dropped by 33.7% and international revenues by 78.9%. Cost of manufactured products decreased by 49.0%, and operating expenses decreased by 29.2%. The company faced challenges in comparing 2023 results to pre-pandemic years due to the surge in pandemic sales. Despite workforce reductions in 2022 and 2023, expenses remain high. The company holds $34.6 million in debt and equity securities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Rhea-AI Summary
Retractable Technologies, Inc. (RVP) declares dividends for its Series II Class B and Series III Class B Convertible Preferred Stock, totaling $39,050.00 and $18,561.25 respectively, covering the period from January 1, 2024, to March 31, 2024. The dividends will be paid on April 22, 2024, to shareholders of record as of April 10, 2024. Retractable manufactures safety medical products like VanishPoint® and Patient Safe® to prevent needlestick injuries and bloodstream infections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
News
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Rhea-AI Summary
Retractable Technologies, Inc. (RVP) has declared dividends for its Series II Class B and Series III Class B Convertible Preferred Stock, totaling $39,050.00 and $18,561.25, respectively. The dividends cover the period from October 1, 2023, to December 31, 2023, at a rate of $1.00 per share per annum. Shareholders of record as of January 10, 2024, will receive the dividends on January 22, 2024. Retractable manufactures safety medical products designed to prevent needlestick injuries and reduce the risk of bloodstream infections. Its products are distributed by various specialty and general line distributors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
dividends
News
Retractable Technologies, Inc. Not Impacted by FDA Safety Communication
Rhea-AI Summary
Retractable Technologies, Inc. (NYSE American: RVP) assures that the recent FDA Safety Communication regarding potential device failures in plastic syringes made in China does not pertain to their VanishPoint Safety Syringe. The company emphasizes that there have been no recent changes to the syringe's dimensions, ensuring the delivery of accurate medication doses and superior needlestick protection for users.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2023
Rhea-AI Summary
Retractable Technologies, Inc. (NYSE American: RVP) reports a loss from operations of $8.7 million for the first nine months of 2023, mainly due to lower sales related to COVID-19 vaccination efforts. The company invested 31% more in sales and marketing expenses in an effort to improve future revenues. Domestic unit sales have increased each quarter of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.96%
Tags
none
-
News
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Rhea-AI Summary
Retractable Technologies, Inc. declares dividends to holders of its preferred stock, totaling $39,050.00 and $19,061.25. Dividends cover the period from July 1, 2023, to September 30, 2023, and will be paid on October 20, 2023. Retractable manufactures safety medical products. Forward-looking statements made.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
dividends
News
Retractable Technologies, Inc. Results for the Period Ended June 30, 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
none
-
News
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
News
Retractable Technologies, Inc. Results for the Period Ended March 31, 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.62%
Tags
none
News
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.13%
Tags
dividends
Stock RVP logo
Retractable Technologies, Inc

NYSE:RVP

RVP Rankings

#4972 Ranked by Market Cap
#4817 Ranked by Stock Gains
N/A Ranked by Dividends

RVP Stock Data

32.63M
13.21M
55.86%
7.8%
0.25%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
LITTLE ELM

About RVP

our vision: through innovation, education, and the development of safe and reliable medical devices, we strive to be a catalyst in reducing the worldwide spread of infectious disease. our mission: to build a model corporation for employees, customers, community, and shareholders based on performance, pride, and profit; to set a standard for excellence, effectiveness, and integrity in selling and delivering our products; and to establish mutually beneficial relationships with other companies who share our overall vision.